Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 1, 2001, Pages 222-228

  Brooks, S E ^a   Gu, X ^a   Samuel, S ^a   Marcus, D M ^a   Bartoli, M ^a   Huang, P L ^a   Caldwell, R B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGEN; PEROXYNITRITE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPEROXIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL OCCLUSION; RETINA CAPILLARY; RETROLENTAL FIBROPLASIA;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; HUMANS; HYPEROXIA; INFANT, NEWBORN; LYMPHOKINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITROARGININE; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035171032     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Retinopathy of prematurity
2. Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture
3. Oxygen-induced retinopathy in the mouse
4. Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity
5. Effect of a water-soluble vitamin E analog, trolox c, on retinal vascular development in an animal model of retinopathy of prematurity
6. Vitamin E in kitten oxygen-induced retinopathy. II. Blockage of vitreal neovascularization
7. Vitamin E protects against retinopathy of prematurity through action on spindle cells
8. Oxygen-induced retinopathy in the rat: Possible contribution of peroxidation reactions
9. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity
10. Vascular endothelial growth factor (VEGF) acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
11. Development of the retinal vasculature is mediated by hypoxia induced vascular endothelial growth factor (VEGF) expression by neuroglia
12. Development of the human retinal vasculature: Cellular relations and VEGF expression
13. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
14. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse
15. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia
16. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase
17. Nitric oxide synthase in models of focal ischemia
18. Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: A study in endothelial NO synthase knockout mice
19. Nitric oxide synthase inhibitors protect rat retina against ischemic injury
20. Inducible nitric oxide synthase in retinal ischemia-reperfusion injury
21. Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina
22. Peroxynitrite and oxidative damage in experimental autoimmune uveitis
23. Plasma 3-nitrotyrosine in elevated in premature infants who develop bronchopulmonary dysplasia
24. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation
25. Peroxynitrite. A biologically significant oxidant
26. Nitric oxide synthetase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury
27. Nitric oxide-induced cytotoxicity: Involvement of cellular resistance to oxidative stress and the role of glutathione in protection
28. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly
29. Role of peroxynitrite (ONOO-) in oxygen-induced retinopathy (OIR)
30. Hypertension in mice lacking the gene for endothelial nitric oxide synthase
31. Astrocytes modulate retinal vasculogenesis: Effects on fibronectin expression
32. Pathological basis of retrolental fibroplasia
33. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
34. Alterations in endothelial superoxide dismutase levels as a function of growth state in vitro
35. Expression of antioxidant protective proteins in the rat retina during prenatal and postnatal development
36. Superoxide dismutase isoenzymes in the human eye
37. Nitric oxide-induced cytotoxicity: Involvement of cellular resistance to oxidative stress and the role of glutathione in protection
38. Glutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage: Implications for neuronal/astrocytic trafficking and neurodegeneration
39. DNA damage and oxidation of thiols peroxynitrite causes in rat thymocytes
40. Protection against peroxynitrate
41. Glutathione status in retinopathy of prematurity
42. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
43. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity
44. Increased gene expression form VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or chronic hypoxia. Modulation of gene expression by nitric oxide
45. Hyproxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
46. The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxictiy